The cistrome and gene signature of androgen receptor splice variants in castration resistant prostate cancer cells.
about
Understanding prostate-specific antigen dynamics in monitoring metastatic castration-resistant prostate cancer: implications for clinical practiceEmerging data on androgen receptor splice variants in prostate cancerThe RNA-binding protein Sam68 regulates expression and transcription function of the androgen receptor splice variant AR-V7Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality.GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex.Androgen receptor variant-7: an important predictive biomarker in castrate resistant prostate cancerTargeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapiesLessons from tissue compartment-specific analysis of androgen receptor alterations in prostate cancer.Refinement of the androgen response element based on ChIP-Seq in androgen-insensitive and androgen-responsive prostate cancer cell lines.FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer.Overview on the complexity of androgen receptor-targeted therapy for prostate cancerClinical relevance of androgen receptor alterations in prostate cancer.Dual effects of constitutively active androgen receptor and full-length androgen receptor for N-cadherin regulation in prostate cancer.DBC1 promotes castration-resistant prostate cancer by positively regulating DNA binding and stability of AR-V7.Targeting AR Variant-Coactivator Interactions to Exploit Prostate Cancer Vulnerabilities.
P2860
Q26748538-B40D257F-EA9B-4FFF-B100-9F82B1F2EE7DQ28077830-CBBBFFCE-0668-4815-8A04-1B3E047AF2F4Q30370955-DC339406-B3DC-406D-90B4-D4F6F7974A61Q33835918-60198BF4-A561-4F86-9DE6-342DFB0B2DB2Q34793424-EB858CBC-54FE-4B48-9DAC-3C5C3C7A4FD5Q35604380-12AD5A3C-5C11-4E50-9328-C82F55C4FC5EQ35842471-78FCB9D1-2BCB-4E82-9474-8ACA80A36D97Q36004694-B9B27674-3515-40BB-A7AB-2FF321D424A8Q37254115-CEF0BAA9-1E08-4C90-8585-88D09E67AD28Q38286227-1440C532-D5D5-447D-9730-1D87C2467843Q38364166-B46DF7C8-525A-4C04-B896-57EB1F82BBCBQ42377108-107C3849-4557-4659-A06D-38AB40FF7305Q42700843-8A2CA8DB-551E-4798-9340-88112DD4614BQ49712140-39AA2EAB-0AA0-4C9C-B2E6-8AEE7F61736FQ52683959-F1264609-5E87-45ED-8349-3A028C9D5ABE
P2860
The cistrome and gene signature of androgen receptor splice variants in castration resistant prostate cancer cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The cistrome and gene signatur ...... sistant prostate cancer cells.
@en
type
label
The cistrome and gene signatur ...... sistant prostate cancer cells.
@en
prefLabel
The cistrome and gene signatur ...... sistant prostate cancer cells.
@en
P2093
P2860
P1476
The cistrome and gene signatur ...... sistant prostate cancer cells.
@en
P2093
Chunxi Wang
Donald J Tindall
Farhad Kosari
George G Klee
George Vasmatzis
Haojie Huang
Liguo Wang
Lucas P Nacusi
Lucy J Schmidt
P2860
P304
P356
10.1016/J.JURO.2014.08.043
P407
P577
2014-08-14T00:00:00Z